tradingkey.logo

AVITA Medical Inc

RCEL
3.900USD
-0.030-0.76%
Close 02/06, 16:00ETQuotes delayed by 15 min
594.62MMarket Cap
LossP/E TTM

AVITA Medical Inc

3.900
-0.030-0.76%

More Details of AVITA Medical Inc Company

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Inc Info

Ticker SymbolRCEL
Company nameAVITA Medical Inc
IPO dateMar 18, 2012
CEOVance (Cary G)
Number of employees260
Security typeOrdinary Share
Fiscal year-endMar 18
Address28159 Avenue Stanford
CityVALENCIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91355
Phone16613679170
Websitehttps://www.avitamedical.com/
Ticker SymbolRCEL
IPO dateMar 18, 2012
CEOVance (Cary G)

Company Executives of AVITA Medical Inc

Name
Name/Position
Position
Shareholding
Change
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
16.03M
93.96%
Japan
605.00K
3.55%
United Kingdom
345.00K
2.02%
Australia
80.00K
0.47%
European Union (Region)
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Other
88.76%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
4.74%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
Other
88.76%
Shareholder Types
Shareholders
Proportion
Investment Advisor
10.83%
Investment Advisor/Hedge Fund
4.52%
Individual Investor
0.80%
Research Firm
0.74%
Hedge Fund
0.62%
Pension Fund
0.25%
Bank and Trust
0.24%
Venture Capital
0.08%
Other
81.93%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
207
5.28M
17.31%
-4.20M
2025Q3
206
7.68M
25.17%
-2.00M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
1.37M
4.48%
-84.89K
-5.85%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
3.51%
-668.22K
-38.45%
Sep 30, 2025
State Street Investment Management (US)
423.31K
1.39%
-105.48K
-19.95%
Sep 30, 2025
Geode Capital Management, L.L.C.
331.46K
1.09%
-286.88K
-46.39%
Sep 30, 2025
Northern Trust Investments, Inc.
158.78K
0.52%
-83.25K
-34.40%
Sep 30, 2025
Millennium Management LLC
132.71K
0.44%
-236.48K
-64.05%
Sep 30, 2025
AQR Capital Management, LLC
119.29K
0.39%
+97.36K
+444.12%
Sep 30, 2025
Bridgeway Capital Management, LLC
118.00K
0.39%
+80.40K
+213.84%
Sep 30, 2025
Divisadero Street Capital Management, LP
100.00K
0.33%
+100.00K
--
Sep 30, 2025
HRT Financial LP
93.03K
0.31%
+93.03K
--
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
View more
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
iShares Micro-Cap ETF
Proportion0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
iShares Russell 3000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI